Briacell Therapeutics Corp BCTX

$4.04 -0.07 (-1.70%)

Valuation

Market cap
35,756,000
Revenue TTM
$0
Net income TTM
$-26,310,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
104,900
Avg volume
325,382
Day's range
$4.01 – $4.33
Shares out
8,700,000
Stochastic %K
23%
Beta
1.21
Analysts
Strong Buy
Price target
$40.00

Price

Company profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator...

Show more

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 921 1810
Website
https://briacell.com
Address
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada

Latest news

Stocktwits

Sb123321 Oct 2, 3:59 PM
$BCTX BCTXZ warrants are priced at a vol of 150%, BCTXL warrants are priced at a vol of 50%. Really doesn't make any sense. You need to buy 10 to convert the BCTXZ into 1 share at a cost of $2.70 ($0.27*10) or buy the lower strike longer life option BCTXL at $1.20. Why are people wasting their money. Do they not understand the conversion terms? If I could gaurantee that I could borrow the XZ (for term) it would be a great arb.
2 replies
Biotechlineup Oct 2, 2:38 PM
$BCTX sharing a chart from Framus-Morrigan . I respect his charts and probably one of the best original technical chart vs AI nonsense some are charging a fortune for. Anyway my personal analysis is based on moving average ribbon expansion (10, 20, 50, 200 SMA/EMA which imo aligns perfectly with his logarithmic candle stick trend channel . Thank you again Framus
3 replies
tbagoni Oct 2, 2:19 PM
$BCTX Lets go! Its my Birthday! 🤑
0 replies
Biotechlineup Oct 2, 1:48 PM
$BCTX Let’s imagine Bctx in a different way . Big Bang happening. 200 day SMA crossed. I see a Pre Super Golden Cross which is a very rare event. After what I consider will be a catalyst of such significance that it completely eliminated all previous charts and analysis. I call that the “Big Bang “ because it’s creating a new mini universe. The 200 day SMA is the Event Horizon, once the share price crosses over the gravitational floor flips the line that acted as a multi year ceiling transforms into a macro floor. Above the 200 SMA there is nothing but expanding Space. No resistance, the previous Universe is gone. The New Solar System is the Expanding ribbon formation of the multiple SMA and EMA .
3 replies
JediGreen Oct 2, 10:51 AM
$BCTX https://renmark-drupal.s3.amazonaws.com/vndr/briacell-therapeutics-corp/2026-09-29-11-00-00/index.html
0 replies
AliceFireSteam Oct 1, 4:35 PM
$BCTX adding another 1k next week
3 replies
Biotechlineup Oct 1, 4:20 PM
$BCTX Technical. We are in a Pre Super Golden cross pattern. Most of the gains of a Golden Cross are prior to the actual event. Called Super because this is a much rarer and even more market moving . Occurs after a severe prolonged devastation decline for many months ( at least 9 months) . Trading well below the 200 day SMA , has crossed all support levels and what I call scrapping the bottom into the Abyss. What happens ? Complex little movement in all SMA . They start rising slowly crawling out like little worms one over each . The 200 SMA day sits high above like surface of the ocean. The 5,10,20,50 SMA and EMA start moving intertwining crossing each other. Bctx did exactly that . Currently we are in an expanding momentum ribbon . The share price today has started reacting to this ribbon formation acting as support and resistance levels. 4.26 the 200 day SMA is a resistance point and pulled back a little. The set up is explosive and exactly what we want.
1 replies
Biotechlineup Oct 1, 1:05 PM
$BCTX Dilution , the Biotech business model. I have been investing and trading in biotech’s since the 1990’s . I was very young , making money and it was the go go nineties. Everything you touched turned to gold. In reality I was i overconfident and inexperienced. I turned my 50-100 G seed money into over a million in a few years then lost it all in 2002 . I learned Dilution is the killer , really is. I posted and warned on this board a year ago about dilution. As soon as I listened to the management presentation, I was certain that dilution was off the table with BCTX . Not happening. I doubled my position as they were talking. They Stated publicly and unambiguously on an official investor roadshow that they have the cash to reach the imminent trial results without dilution, management has bound themselves to strict regulatory and legal restrictions under guidelines SEC Rule10b 5. A key word was “ Ample” Lawsuits and possible jail time. They even mentioned partnerships and grants
1 replies